Jazz Pharmaceuticals plc (JAZZ)
USD 105.21
(-4.39%)
USD 105.21
(-4.39%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 3.39 Billion USD | -10.53% |
| 2022 | 3.11 Billion USD | 17.54% |
| 2021 | 2.65 Billion USD | 19.81% |
| 2020 | 2.21 Billion USD | 8.89% |
| 2019 | 2.03 Billion USD | 14.95% |
| 2018 | 1.76 Billion USD | 17.29% |
| 2017 | 1.5 Billion USD | 9.11% |
| 2016 | 1.38 Billion USD | 13.12% |
| 2015 | 1.22 Billion USD | 15.81% |
| 2014 | 1.05 Billion USD | 37.02% |
| 2013 | 770.27 Million USD | 51.76% |
| 2012 | 507.55 Million USD | 96.47% |
| 2011 | 258.33 Million USD | 61.24% |
| 2010 | 160.22 Million USD | 34.85% |
| 2009 | 118.81 Million USD | 121.7% |
| 2008 | 53.59 Million USD | -4.98% |
| 2007 | 56.4 Million USD | 48.86% |
| 2006 | 37.88 Million USD | 120.92% |
| 2005 | 17.15 Million USD | 0.0% |
| 2004 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 650.76 Million USD | -13.59% |
| 2024 Q2 | 758.7 Million USD | 16.59% |
| 2023 Q2 | 859.78 Million USD | 12.51% |
| 2023 FY | 2.79 Billion USD | -10.53% |
| 2023 Q4 | 753.13 Million USD | -13.43% |
| 2023 Q3 | 869.98 Million USD | 1.19% |
| 2023 Q1 | 764.16 Million USD | -5.04% |
| 2022 Q2 | 808.67 Million USD | 15.78% |
| 2022 Q1 | 698.43 Million USD | -8.17% |
| 2022 FY | 3.11 Billion USD | 17.54% |
| 2022 Q4 | 804.75 Million USD | -0.28% |
| 2022 Q3 | 806.99 Million USD | -0.21% |
| 2021 Q3 | 692.89 Million USD | 9.53% |
| 2021 Q1 | 567.39 Million USD | -7.8% |
| 2021 Q2 | 632.61 Million USD | 11.5% |
| 2021 Q4 | 760.57 Million USD | 9.77% |
| 2021 FY | 2.65 Billion USD | 19.81% |
| 2020 Q3 | 558.79 Million USD | 4.56% |
| 2020 FY | 2.21 Billion USD | 8.89% |
| 2020 Q4 | 615.36 Million USD | 10.12% |
| 2020 Q1 | 506.06 Million USD | -7.38% |
| 2020 Q2 | 534.42 Million USD | 5.6% |
| 2019 FY | 2.03 Billion USD | 14.95% |
| 2019 Q2 | 506.45 Million USD | 6.69% |
| 2019 Q3 | 506.3 Million USD | -0.03% |
| 2019 Q4 | 546.39 Million USD | 7.92% |
| 2019 Q1 | 474.68 Million USD | 5.46% |
| 2018 FY | 1.76 Billion USD | 17.29% |
| 2018 Q4 | 450.12 Million USD | 1.65% |
| 2018 Q3 | 442.79 Million USD | -4.93% |
| 2018 Q2 | 465.76 Million USD | 13.41% |
| 2018 Q1 | 410.69 Million USD | -0.11% |
| 2017 Q1 | 350.98 Million USD | -3.3% |
| 2017 FY | 1.5 Billion USD | 9.11% |
| 2017 Q4 | 411.15 Million USD | 8.01% |
| 2017 Q3 | 380.65 Million USD | 4.08% |
| 2017 Q2 | 365.71 Million USD | 4.2% |
| 2016 FY | 1.38 Billion USD | 13.12% |
| 2016 Q1 | 312.57 Million USD | -1.35% |
| 2016 Q4 | 362.96 Million USD | 3.74% |
| 2016 Q3 | 349.87 Million USD | -2.05% |
| 2016 Q2 | 357.18 Million USD | 14.27% |
| 2015 Q3 | 312.48 Million USD | 0.18% |
| 2015 FY | 1.22 Billion USD | 15.81% |
| 2015 Q1 | 281 Million USD | -6.12% |
| 2015 Q2 | 311.93 Million USD | 11.01% |
| 2015 Q4 | 316.85 Million USD | 1.4% |
| 2014 Q2 | 260.53 Million USD | 20.62% |
| 2014 FY | 1.05 Billion USD | 37.02% |
| 2014 Q1 | 215.99 Million USD | 2.79% |
| 2014 Q4 | 299.33 Million USD | 7.06% |
| 2014 Q3 | 279.59 Million USD | 7.31% |
| 2013 Q4 | 210.13 Million USD | 1.07% |
| 2013 FY | 770.27 Million USD | 51.76% |
| 2013 Q2 | 183.22 Million USD | 8.4% |
| 2013 Q1 | 169.01 Million USD | 7.01% |
| 2013 Q3 | 207.9 Million USD | 13.47% |
| 2012 Q2 | 114.16 Million USD | 16.91% |
| 2012 FY | 507.55 Million USD | 96.47% |
| 2012 Q1 | 97.65 Million USD | 22.57% |
| 2012 Q4 | 157.94 Million USD | 10.54% |
| 2012 Q3 | 142.88 Million USD | 25.15% |
| 2011 Q1 | 48.07 Million USD | -1.06% |
| 2011 Q2 | 61.19 Million USD | 27.3% |
| 2011 Q3 | 69.39 Million USD | 13.39% |
| 2011 Q4 | 79.67 Million USD | 14.82% |
| 2011 FY | 258.33 Million USD | 61.24% |
| 2010 FY | 160.22 Million USD | 34.85% |
| 2010 Q2 | 37.68 Million USD | 16.7% |
| 2010 Q1 | 32.29 Million USD | -9.04% |
| 2010 Q4 | 48.58 Million USD | 16.62% |
| 2010 Q3 | 41.66 Million USD | 10.56% |
| 2009 Q3 | 28.47 Million USD | -17.96% |
| 2009 Q4 | 35.5 Million USD | 24.7% |
| 2009 FY | 118.81 Million USD | 121.7% |
| 2009 Q2 | 34.7 Million USD | 72.38% |
| 2009 Q1 | 20.13 Million USD | 23.59% |
| 2008 Q3 | 12.22 Million USD | -4.1% |
| 2008 Q4 | 16.29 Million USD | 33.3% |
| 2008 Q1 | 12.33 Million USD | 1.16% |
| 2008 Q2 | 12.74 Million USD | 3.3% |
| 2008 FY | 53.59 Million USD | -4.98% |
| 2007 Q1 | 12.08 Million USD | 3.53% |
| 2007 Q4 | 12.19 Million USD | -37.58% |
| 2007 Q2 | 12.58 Million USD | 4.14% |
| 2007 Q3 | 19.53 Million USD | 55.23% |
| 2007 FY | 56.4 Million USD | 48.86% |
| 2006 Q4 | 11.67 Million USD | 0.0% |
| 2006 FY | 37.88 Million USD | 120.92% |
| 2006 Q1 | 9.83 Million USD | 83.53% |
| 2006 Q2 | 11.67 Million USD | 18.66% |
| 2006 Q3 | 11.67 Million USD | 0.0% |
| 2005 Q4 | 5.36 Million USD | -0.02% |
| 2005 Q2 | 5.36 Million USD | 0.0% |
| 2005 FY | 17.15 Million USD | 0.0% |
| 2005 Q1 | 5.36 Million USD | 0.0% |
| 2005 Q3 | 5.36 Million USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -8837.875% |
| Alkermes plc | 1.37 Billion USD | -147.231% |
| Agenus Inc. | 139.61 Million USD | -2334.285% |
| Aptorum Group Limited | -1.11 Million USD | 304994.912% |
| Ardelyx, Inc. | 106.66 Million USD | -3086.382% |
| Dyadic International, Inc. | 922.95 Thousand USD | -368132.431% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -16037.064% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 1943916.452% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 25542.923% |
| Novavax, Inc. | 639.93 Million USD | -431.088% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 7355.977% |
| Pyxis Oncology, Inc. | -2 Million USD | 170031.35% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 657797.786% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -17747.12% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 7691389.49% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 645000.759% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 3560.325% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -423668.953% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 4144767.073% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -2412.495% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -43079.1% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 3605.546% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | -123.905% |
| AlloVir, Inc. | -398 Thousand USD | 854026.382% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -1311.771% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -801462.972% |
| Bicycle Therapeutics plc | -129.52 Million USD | 2724.017% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -2832089.167% |
| ChromaDex Corporation | 50.78 Million USD | -6592.846% |
| Chimerix, Inc. | 324 Thousand USD | -1048858.951% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 11004.338% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 4479.787% |
| CRISPR Therapeutics AG | 240.95 Million USD | -1310.476% |
| Precision BioSciences, Inc. | 40.47 Million USD | -8297.477% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 3562.228% |
| Fortress Biotech, Inc. | 57.85 Million USD | -5774.591% |
| Fortress Biotech, Inc. | 57.85 Million USD | -5774.591% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -20402.063% |
| ImmuCell Corporation | 4.39 Million USD | -77206.812% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 3302.536% |
| Immix Biopharma, Inc. | -5468.00 USD | 62154946.379% |
| Incyte Corporation | 3.44 Billion USD | 1.221% |
| Innoviva, Inc. | 261.06 Million USD | -1201.832% |
| IO Biotech, Inc. | -756 Thousand USD | 449653.836% |
| Jaguar Health, Inc. | 7.72 Million USD | -43900.867% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 511941.416% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -2738.031% |
| ContextLogic Inc. | 59 Million USD | -5660.385% |
| MiMedx Group, Inc. | 266.84 Million USD | -1173.643% |
| MEI Pharma, Inc. | 49.32 Million USD | -6789.993% |
| NextCure, Inc. | -3.68 Million USD | 92353.719% |
| Onconetix, Inc. | -1.12 Million USD | 301619.919% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 11832.349% |
| Opthea Limited | 21.72 Thousand USD | -15647353.959% |
| Psyence Biomedical Ltd. | -240.00 USD | 1416094683.333% |
| Vaxcyte, Inc. | -75 Million USD | 4631.503% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 5928696.1% |
| Precigen, Inc. | 106 Thousand USD | -3206151.887% |
| Pharming Group N.V. | 220.1 Million USD | -1444.101% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -659827.573% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -336731.219% |
| PureTech Health plc | -1.6 Million USD | 212116.656% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -2996.078% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 1973.471% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 7598.35% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 15557.438% |
| Acelyrin, Inc. | -115 Thousand USD | 2955427.826% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 33813919.52% |
| Summit Therapeutics Inc. | -2.05 Million USD | 165886.683% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 595306.13% |
| Senti Biosciences, Inc. | -2.68 Million USD | 126772.643% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -83796.001% |
| Elevation Oncology, Inc. | -39 Thousand USD | 8714528.205% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 70934.243% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 86314.754% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -11567.503% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -685107.056% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 6179421.818% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -3164.803% |
| Seer, Inc. | 7.02 Million USD | -48265.263% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -77529.671% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -15674.551% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 2868357.505% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 2371770.121% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -557966.831% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -2721.046% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -983.497% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 67972640.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -131936.791% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 6698221.797% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -11465.07% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 1465025.431% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 690877.846% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 47981.474% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 716286.452% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 32679205.769% |
| Soligenix, Inc. | 97.31 Thousand USD | -3492441.439% |
| Century Therapeutics, Inc. | -10.8 Million USD | 31542.566% |
| Kura Oncology, Inc. | -849 Thousand USD | 400409.423% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 5164.716% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 2312091.156% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -3331.605% |
| Autolus Therapeutics plc | -4.86 Million USD | 69930.018% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -8112.021% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 2023092.262% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -3487.964% |
| GRI Bio, Inc. | 10.84 Million USD | -31249.756% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -133704.95% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 39223.138% |
| IGM Biosciences, Inc. | -211.66 Million USD | 1705.701% |
| INmune Bio, Inc. | 155 Thousand USD | -2192562.581% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -5387.055% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 225728.846% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 524212.273% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 11609811.69% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -845329.602% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 170371.894% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 1085923.323% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -3497.916% |
| Verastem, Inc. | -62 Thousand USD | 5481756.452% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -139474.004% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 1302255.939% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -112177.073% |
| Histogen Inc. | 3.76 Million USD | -90073.176% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -589756.104% |
| Surrozen, Inc. | -27.23 Million USD | 12581.186% |
| Organovo Holdings, Inc. | -5.38 Million USD | 63166.005% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 282171.825% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 13351.558% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -16849.067% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 171647928.283% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -55923.574% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 5062778.941% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -2095.623% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -2330919.89% |
| Apollomics, Inc. | 127 Thousand USD | -2675984.252% |
| Amarin Corporation plc | 165.54 Million USD | -1953.042% |
| Mesoblast Limited | -9.81 Million USD | 34726.867% |
| Turnstone Biologics Corp. | 16.5 Million USD | -20490.252% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 3175.987% |
| Synaptogenix, Inc. | -6347.00 USD | 53547082.827% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 6664074.51% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -2006.174% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | -93.361% |
| Better Therapeutics, Inc. | -2.72 Million USD | 124637.45% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 3130.133% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -905.27% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 29791711.15% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 54391.166% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 306835.289% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -46342.013% |
| Insmed Incorporated | 239.63 Million USD | -1318.252% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -94886.78% |
| OmniAb, Inc. | 14.66 Million USD | -23071.93% |
| Alector, Inc. | -95.05 Million USD | 3675.507% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -2605.461% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 7919.587% |
| Zai Lab Limited | 170.9 Million USD | -1888.629% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -4050.893% |
| Aura Biosciences, Inc. | -1.29 Million USD | 262542.239% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -2614228.462% |
| Immunic, Inc. | -111 Thousand USD | 3061926.126% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -21337.032% |
| Veracyte, Inc. | 248.14 Million USD | -1269.597% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 148.628% |
| FibroGen, Inc. | 128.9 Million USD | -2536.557% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 602593539.716% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 29230.543% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -873583.033% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -856.43% |
| TG Therapeutics, Inc. | 219.1 Million USD | -1451.12% |
| Galecto, Inc. | -830 Thousand USD | 409573.133% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 245488.231% |
| Fortrea Holdings Inc. | 424 Million USD | -701.563% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 4044.233% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 599505.115% |
| XBiotech Inc. | -1.74 Million USD | 194975.401% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 306835.289% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 7413.436% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 4599.466% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -4530.093% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -20126.311% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | -773.593% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 6945.584% |
| Vaxxinity, Inc. | -2.23 Million USD | 152231.916% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -940.127% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 30113.02% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -13799.746% |
| NexImmune, Inc. | -1.02 Million USD | 331682.424% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -62937437.037% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 47929.884% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 69.927% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 5085809.369% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 95809.012% |
| Ainos, Inc. | -253.73 Thousand USD | 1339550.131% |
| Pluri Inc. | 322 Thousand USD | -1055374.224% |
| Prothena Corporation plc | -129.2 Million USD | 2730.496% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -6640.106% |
| Celularity Inc. | 6.75 Million USD | -50212.761% |
| Rallybio Corporation | -150 Thousand USD | 2265851.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | 10522.998% |
| MeiraGTx Holdings plc | 287 Thousand USD | -1184090.592% |
| Omeros Corporation | -69.77 Million USD | 4970.558% |
| Humacyte, Inc. | -76.55 Million USD | 4539.748% |
| Immunocore Holdings plc | 248.39 Million USD | -1268.257% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 22505.083% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -5348.089% |
| Blueprint Medicines Corporation | 236.58 Million USD | -1336.541% |
| CalciMedica, Inc. | -58 Thousand USD | 5859801.724% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 238432.889% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -11597.219% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 119601.653% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 11111.265% |
| Pulmatrix, Inc. | -8.22 Million USD | 41445.827% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 290580.94% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 851886.216% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 952.226% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -122347.232% |
| Cytokinetics, Incorporated | -322.59 Million USD | 1153.534% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -394124.253% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 996764.809% |
| Vor Biopharma Inc. | -3.49 Million USD | 97426.088% |
| Roivant Sciences Ltd. | 109.23 Million USD | -3011.299% |
| Evogene Ltd. | 1.39 Million USD | -242832.595% |
| ProKidney Corp. | -3.16 Million USD | 107346.04% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 7839.632% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -49464.343% |
| CorMedix Inc. | -205.56 Thousand USD | 1653434.274% |
| BioLineRx Ltd. | 1.1 Million USD | -306635.289% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 4420.051% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 10298969.697% |
| Atai Life Sciences N.V. | -5000.00 USD | 67972640.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 2789083.169% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 3540336.458% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 244781.569% |
| Sagimet Biosciences Inc. | 2 Million USD | -169831.35% |
| MediciNova, Inc. | 979.7 Thousand USD | -346803.098% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 4130.678% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 3594438.745% |
| GeoVax Labs, Inc. | -20.72 Million USD | 16502.034% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -1289.833% |
| Biomea Fusion, Inc. | -4.2 Million USD | 81000.428% |
| PTC Therapeutics, Inc. | 872.33 Million USD | -289.601% |
| Mereo BioPharma Group plc | 7.42 Million USD | -45666.59% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 1096431.29% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 28321991.667% |
| Absci Corporation | -41.84 Million USD | 8221.167% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 67972640.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 4550.037% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 138199.431% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -1490.113% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 361271.838% |
| Allakos Inc. | -6.14 Million USD | 55443.218% |
| Imunon, Inc. | -720 Thousand USD | 472128.25% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 5025.832% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | -614.156% |
| BioAtla, Inc. | -103.73 Million USD | 3376.385% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 29791711.15% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 1909441.011% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 1499.654% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 1092906.109% |
| XOMA Corporation | 3.86 Million USD | -87924.527% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 4949.293% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -22873.009% |
| aTyr Pharma, Inc. | -2.38 Million USD | 142421.064% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -27176.3% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 11719503.448% |
| Viridian Therapeutics, Inc. | -1 Million USD | 337265.377% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -26143284515.385% |
| Akari Therapeutics, Plc | -4000.00 USD | 84965775.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | -433.627% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -1745399.415% |
| UroGen Pharma Ltd. | 73.35 Million USD | -4533.312% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 12831.801% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -29273173.04% |
| Orgenesis Inc. | -5.72 Million USD | 59464.664% |
| Entera Bio Ltd. | -56 Thousand USD | 6069076.786% |
| GH Research PLC | -315 Thousand USD | 1079029.206% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 1798315.344% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 647457.524% |
| Xencor, Inc. | -85.26 Million USD | 4086.192% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 1538100.335% |
| Replimune Group, Inc. | -2.65 Million USD | 128108.55% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 339543.148% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -1811.016% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -1745399.415% |
| Portage Biotech Inc. | -54 Thousand USD | 6293853.704% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 3594438.745% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 901592.573% |
| OncoCyte Corporation | 413 Thousand USD | -822812.107% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 75609154.505% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 1530913163.063% |
| Purple Biotech Ltd. | -196 Thousand USD | 1734093.367% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -37797.268% |
| scPharmaceuticals Inc. | 9.78 Million USD | -34643.682% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 32638.449% |
| HilleVax, Inc. | -2.15 Million USD | 157735.761% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 3503839.175% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 22651572.941% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 508876.497% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 14776739.13% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 45277938.469% |
| Savara Inc. | -44.26 Million USD | 7778.431% |
| Curis, Inc. | 9.81 Million USD | -34540.985% |
| Daré Bioscience, Inc. | 2.76 Million USD | -122615.292% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 2723620.691% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 196666.05% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 1490725.877% |
| BeiGene, Ltd. | 2.07 Billion USD | -63.485% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 121657.531% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 950.371% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -5895.32% |
| Erasca, Inc. | -3.73 Million USD | 91167.176% |
| bluebird bio, Inc. | -4.03 Million USD | 84433.176% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 12044281.019% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | -78.464% |
| DBV Technologies S.A. | 15.72 Million USD | -21508.768% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 12044281.019% |
| Moderna, Inc. | 2.15 Billion USD | -57.709% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 371534.645% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -42350.999% |
| Molecular Templates, Inc. | 50.39 Million USD | -6643.977% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 634172.201% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -2440.308% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 54722.742% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 8738.454% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 3158.299% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 94822.046% |
| MacroGenics, Inc. | 50.52 Million USD | -6626.358% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 55833.47% |
| Prime Medicine, Inc. | -147.9 Million USD | 2397.845% |
| Aditxt, Inc. | -111.66 Thousand USD | 3043828.282% |
| Adagene Inc. | 18.11 Million USD | -18665.032% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -696339.959% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -2324.093% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -2053.265% |
| SciSparc Ltd. | 2.19 Million USD | -154664.435% |
| Vericel Corporation | 135.57 Million USD | -2406.806% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 13568014.887% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 10969782.396% |
| Generation Bio Co. | -73.91 Million USD | 4698.27% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 777817.849% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -6122.426% |
| Invivyd, Inc. | -2.02 Million USD | 167685.158% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 1229.709% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 3285765.809% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -3426.717% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -3357.825% |
| ADMA Biologics, Inc. | 88.21 Million USD | -3752.532% |
| Clene Inc. | 533 Thousand USD | -637541.088% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -13996.815% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 355233.438% |
| GeoVax Labs, Inc. | -20.72 Million USD | 16502.034% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -170857.093% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 1749120.667% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -6723.867% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 48021.983% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 406634.33% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -3974.36% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -4648421.447% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -6292.963% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 2062.392% |
| Trevena, Inc. | 1.45 Million USD | -233482.612% |
| Surrozen, Inc. | -27.23 Million USD | 12581.186% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 962883.853% |
| Cingulate Inc. | -582.91 Thousand USD | 583136.894% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 10963412.903% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 17352.789% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 44896097.358% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 385869.24% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | -399.28% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 344090.587% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 6032237.659% |
| Kronos Bio, Inc. | 1.37 Million USD | -247613.338% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 6432.924% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 1164013.356% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 696092.128% |
| ImmunityBio, Inc. | -17.89 Million USD | 19097.356% |
| Korro Bio, Inc. | -3.63 Million USD | 93726.088% |
| Kineta, Inc. | 5.43 Million USD | -62455.255% |
| BioVie Inc. | -229.37 Thousand USD | 1481777.326% |
| Codexis, Inc. | 57.33 Million USD | -5827.769% |
| Celularity Inc. | 6.75 Million USD | -50212.761% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -84590.431% |
| Celcuity Inc. | -142.77 Thousand USD | 2380557.653% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -6717881.815% |
| Cibus, Inc. | 1.42 Million USD | -238903.305% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 908823.797% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 14928.863% |
| IN8bio, Inc. | -2.5 Million USD | 135990.724% |
| Kodiak Sciences Inc. | -25.94 Million USD | 13198.343% |
| Annexon, Inc. | -3.26 Million USD | 104128.987% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 166373.337% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 8242.959% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -530935.469% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | -336.553% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -1865.035% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 178975.105% |
| Arcellx, Inc. | 108.27 Million USD | -3038.768% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 10599.635% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -4190.979% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 16167.639% |
| Moolec Science SA | -143.3 Thousand USD | 2371703.922% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 8131.162% |
| Geron Corporation | -123.5 Million USD | 2851.858% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -103296.015% |
| Royalty Pharma plc | 1.79 Billion USD | -89.455% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 4948.947% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 94092763.344% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -1468680.981% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 3150.449% |
| Humacyte, Inc. | -76.55 Million USD | 4539.748% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 358161.536% |
| 89bio, Inc. | -273 Thousand USD | 1245018.315% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 270476.054% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 400881.486% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 2763211.382% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -303620.018% |
| Notable Labs, Ltd. | 113 Thousand USD | -3007534.513% |
| Liquidia Corporation | 14.6 Million USD | -23178.267% |
| Mustang Bio, Inc. | -2.22 Million USD | 152847.281% |
| Immunovant, Inc. | -231 Thousand USD | 1471367.1% |
| Quantum-Si incorporated | 488 Thousand USD | -696339.959% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 6217.149% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 11328856.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -182425.618% |
| Acasti Pharma Inc. | -11 Thousand USD | 30896709.091% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 1661070.007% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 524212.273% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 2128.886% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -299449.349% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 892128.084% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 173676.456% |
| PepGen Inc. | -1.18 Million USD | 287146.199% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 2676184.252% |
| United Therapeutics Corporation | 2.07 Billion USD | -64.185% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 14943.11% |
| Solid Biosciences Inc. | -76.56 Million USD | 4538.994% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 4115507.529% |
| Immuneering Corporation | -764.13 Thousand USD | 444866.129% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -5128819.172% |
| Belite Bio, Inc | -399 Thousand USD | 851886.216% |
| XOMA Corporation | 3.86 Million USD | -87924.527% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 17062.602% |
| Bionomics Limited | -434.44 Thousand USD | 782384.457% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 316545.717% |
| uniQure N.V. | 2.21 Million USD | -153336.885% |
| Cassava Sciences, Inc. | -89.42 Million USD | 3900.618% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 3791.391% |
| Forte Biosciences, Inc. | -9000.00 USD | 37762622.222% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 407121.198% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 777817.849% |
| Altimmune, Inc. | -65.37 Million USD | 5298.824% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -838.769% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 316545.717% |
| Compugen Ltd. | 31.45 Million USD | -10704.727% |
| Peak Bio, Inc. | 367.76 Thousand USD | -924020.032% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -13762.894% |
| Benitec Biopharma Inc. | 108 Thousand USD | -3146776.852% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 4357314.103% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 282612.635% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 186632.766% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 2856089.076% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 282612.635% |
| Instil Bio, Inc. | -4.75 Million USD | 71559.777% |
| argenx SE | 1.1 Billion USD | -206.602% |
| Immunome, Inc. | -8.9 Million USD | 38256.809% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 179921.534% |
| Verona Pharma plc | -679.62 Thousand USD | 500174.6% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 1942172.571% |
| Shattuck Labs, Inc. | -2.38 Million USD | 142600.084% |
| CervoMed Inc. | -1.29 Million USD | 262820.784% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 141297.632% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 71245.635% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -137440.55% |
| Moolec Science SA | -143.3 Thousand USD | 2371703.922% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 833035.568% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 127316.597% |
| AnaptysBio, Inc. | 14.78 Million USD | -22893.214% |
| Design Therapeutics, Inc. | -537 Thousand USD | 632991.434% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 796031.382% |
| NeurAxis, Inc. | 2.15 Million USD | -157484.305% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -158270.317% |
| Lumos Pharma, Inc. | 2 Million USD | -169238.665% |
| Achilles Therapeutics plc | -4.73 Million USD | 71933.338% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 1942172.571% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 3216212.609% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -10635.189% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -394124.253% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 329424.322% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 7561.638% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -7903683.721% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 413558.273% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 25829458.565% |
| Palisade Bio, Inc. | 246 Thousand USD | -1381455.691% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 10298969.697% |
| Beam Therapeutics Inc. | -59.67 Million USD | 5795.514% |
| Neurogene Inc. | -3.26 Million USD | 104288.443% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -2339.177% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 92153.819% |
| Sesen Bio, Inc. | 40 Million USD | -8396.568% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 1144418.855% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 84495.227% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 35628.194% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -24037.976% |
| Athira Pharma, Inc. | -969 Thousand USD | 350835.501% |
| Vaccinex, Inc. | -16 Million USD | 21336.11% |
| HCW Biologics Inc. | -574.82 Thousand USD | 591346.538% |
| XOMA Corporation | 3.86 Million USD | -87924.527% |
| Nektar Therapeutics | 53.47 Million USD | -6255.187% |
| Arvinas, Inc. | 71.8 Million USD | -4633.464% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 4172.113% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 5513.982% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 1055574.224% |
| Rezolute, Inc. | -36 Thousand USD | 9440730.556% |
| Clene Inc. | 533 Thousand USD | -637541.088% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 264690676.324% |
| BeyondSpring Inc. | 1.75 Million USD | -193996.345% |
| Synlogic, Inc. | -1.92 Million USD | 176743.815% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 9185578.378% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 53773.831% |
| Peak Bio, Inc. | 367.76 Thousand USD | -924020.032% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 18022.412% |
| Krystal Biotech, Inc. | 47.6 Million USD | -7039.223% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -2308.819% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -67534.368% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 131360.701% |
| MannKind Corporation | 136.19 Million USD | -2395.486% |
| Ikena Oncology, Inc. | -50.49 Million USD | 6831.021% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -3023.336% |
| Gossamer Bio, Inc. | -4.38 Million USD | 77605.747% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 1348761.508% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 67972640.0% |
| Legend Biotech Corporation | 140.92 Million USD | -2311.588% |
| Mural Oncology plc | -2.56 Million USD | 132496.845% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 616910.708% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 3398727.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -16275.769% |
| REGENXBIO Inc. | 53.02 Million USD | -6308.997% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 63543.286% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 1766767.706% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 196325.577% |
| Vaxart, Inc. | -60.76 Million USD | 5693.251% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 1293435.49% |
| Cellectis S.A. | 18 Thousand USD | -18881161.111% |
| Longeveron Inc. | 221 Thousand USD | -1537740.271% |
| Repare Therapeutics Inc. | -80.07 Million USD | 4344.57% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | -210.947% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 262745.054% |
| Revolution Medicines, Inc. | -399.66 Million USD | 950.371% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 9710462.857% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -6935873.469% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 60.513% |
| Denali Therapeutics Inc. | -93.34 Million USD | 3740.931% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 13568014.887% |
| Veru Inc. | 7.56 Million USD | -44820.16% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 2250846.358% |
| Cingulate Inc. | -582.91 Thousand USD | 583136.894% |
| Passage Bio, Inc. | -3.72 Million USD | 91436.388% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 28218524.112% |
| Exicure, Inc. | -1.42 Million USD | 238935.348% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 887469.974% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -125635.368% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 663020.369% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -4888.737% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 2271803.196% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 5840.342% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -869114.066% |
| OmniAb, Inc. | 14.66 Million USD | -23071.93% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -16899.085% |
| Lipocine Inc. | -2.85 Million USD | 119315.853% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 184507.325% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 59672.778% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 225728.846% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -4412.49% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 5228756.923% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -3931.777% |
| Ocugen, Inc. | -33.53 Million USD | 10233.962% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 107583.46% |
| Q32 Bio Inc. | 578 Thousand USD | -587897.751% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 1282600.755% |
| Alumis Inc. Common Stock | -1.28 Million USD | 264790.576% |
| Equillium, Inc. | 35.95 Million USD | -9351.657% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 199199.414% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -678703.585% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 82211686.841% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 1312311.197% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -803905.328% |
| Dominari Holdings Inc. | 2.03 Million USD | -166581.069% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 1852505.557% |
| vTv Therapeutics Inc. | -13.59 Million USD | 25099.095% |
| Bio-Techne Corporation | 773.07 Million USD | -339.625% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -19523.691% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | -637.572% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 290829.427% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 14272.756% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -28955.544% |
| Nkarta, Inc. | -5.86 Million USD | 58008.11% |
| BioCardia, Inc. | -7.24 Million USD | 46984.081% |
| Iterum Therapeutics plc | -1.75 Million USD | 194307.257% |